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Abstract
Asymptomatic colonization with extended-spectrum beta-lactamase (ESBL) producing
Enterobacteriaceae has been described for humans, various mammal species, and birds.
Here, antimicrobial resistant bacteria were recovered from dog feces originating in Ger-
many, Kosovo, Afghanistan, Croatia, and Ukraine, with a subset of mostly E. coli isolates
obtained from a longitudinal collection over twelve months. In vitro antimicrobial resistance
testing revealed various patterns of resistance against single or all investigated beta-lactam
antibiotics, with none of the 101 isolates resistant against two tested carbapenem antibiot-
ics. Whole genome sequence analysis revealed bacteria species-specific patterns for 23
antimicrobial resistance coding DNA sequences (CDS) that were unapparent from the in
vitro analysis alone. Phylogenetic analysis of single nucleotide polymorphisms (SNP)
revealed clonal bacterial isolates originating from different dogs, suggesting transmission
between dogs in the same community. However, individual resistant E. coli clones were not
detected over a period longer than seven days. Multi locus sequence typing (MLST) of 85 E.
coli isolates revealed 31 different sequence types (ST) with an accumulation of ST744 (n =
9), ST10 (n = 8), and ST648 (n = 6), although the world-wide hospital-associated CTX-M
beta-lactamase producing ST131 was not detected. Neither the antimicrobial resistance
CDSs patterns nor the phylogenetic analysis revealed an epidemiological correlation
among the longitudinal isolates collected from a period longer than seven days. No genetic
linkage could be associated with the geographic origin of isolates. In conclusion, healthy
dogs frequently carry ESBL-producing bacteria, independent to prior treatment, which may
be transmitted between individual dogs of the same community. Otherwise, these antimicro-
bial resistant bacteria share few commonalities, making their presence eerily unpredictable.
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Introduction
Beta-lactams are among the most popular antibiotics, worldwide, for the treatment of bacterial
infections [1]. Unfortunately, multidrug-resistant bacteria producing extended-spectrum beta-
lactamases (ESBL) are also prevalent worldwide [2]. Descriptions of ESBL isolates originating
from patients in intensive care units of European hospitals were first published in the mid-
1980s [1]. Since then, ESBL-producing Enterobacteriaceae have been identified from a pleth-
ora of sources, including humans, animals, food, feed, and other environmental sources [3–7].
ESBL-producing Escherichia coli isolated from dogs were first described in 1988, following
treatment of the dogs with beta-lactam antibiotics [8]. Since then, the presence of ESBL-pro-
ducing bacteria has been described repeatedly for sick, but also completely healthy companion
animals, including dogs [4,9–13]. One longitudinal study occurring over six months identified
a variety of ESBL-producing Enterobacteriaceae in healthy dogs with highly dynamic fecal
shedding patterns, occurring either continuously or periodically [14].
Comprehensive characterization of ESBL-producing Enterobacteriaceae is critical for
understanding transmission routes and persistence in potential reservoirs, as well as their
potential to transfer multidrug-resistant genetic coding elements and/or cause disease [15]. To
date, a variety of methods, including biochemistry, phage typing, serotyping, bacteriocin typ-
ing, analytical isoelectric focusing, and pulsed-field gel electrophoresis have been used for
characterization [1, 9, 16–17]. However, the discriminatory power of these methods has been
incomplete and the reproducibility among different laboratories low, limiting insight into the
epidemiology of these bacteria [1]. High throughput whole genome sequencing provides an
opportunity to gather much more comprehensive data on antimicrobial resistance carrying
genetic elements in various bacteria. And, when coupled with appropriate epidemiological
data, should allow for greater insight into the population dynamics of ESBL-producing bacte-
ria [17–19]. In this study, we combine in vitro diagnostics with whole genome analysis to
investigate the genetic diversity and antimicrobial resistance profiles of ESBL-producing bacte-
ria from dogs living in close proximity to humans and gain a greater understanding of this
overlooked source of antimicrobial resistance.
Material and methods
Strain isolation
ESBL-producing bacteria were exclusively isolated from fresh canine feces. As the dogs were
not at all touched for this purpose, the Institutional Animal Care and Use Committee
(IACUC) was not involved. The authorization of the sample collection regarding animals
within any North Atlantic Treaty Organization (NATO) theatre of operations was given by
direct NATO order and was to be executed by the military veterinary authorities, here authors
of the present study, that must review which diseases were prevalent in the area to which ani-
mals will be deployed [20]. The collection within Germany was carried out within the area of
caserns or on private land in the presence of and in accordance to the commanding officer or
the respective landlord.
Dog feces from a community of 17 German (GER) military dogs, and from three additional
military dogs living in a different community, was sampled over a twelve-month period, from
April 2015 to March 2016. Within this longitudinal subset, fecal samples of all dogs were
screened daily within the first week of investigation, then weekly during the first month, then
monthly for six months, and, finally, once at the end of twelve months. The sampled dogs had
no history of treatment over the previous twelve months. Additional, sporadic samples were
collected from military dogs from other locations, including Croatia (CRO) and Ukraine
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(UKR), and also from stray dogs from military operation zones in Afghanistan (AFG) and
Kosovo (KOS) (S1 Table). Samples were collected from dog feces directly after voiding, and
were processed in the laboratory within a maximum of six hours. Initial screening of fecal sam-
ples was carried out by direct inoculation on a selective Brilliance ESBL AGAR (Oxoid, Wesel,
Germany) containing an antibiotic-mix, using a 10 μl inoculation loop. Plates were incubated
at 37˚C, and putative isolates were harvested based on their colony morphology after 24 h
according to the manufacturer’s instructions. All morphologically suspicious isolates were
picked, with at least three morphologically indistinguishable isolates selected per plate, if avail-
able. Selected isolates were then sub-cultured on Columbia sheep blood agar (Oxoid, Wesel,
Germany). The tentative species of each isolate was determined via mass spectrometry using a
MALDI Biotyper system (Bruker, Bremen, Germany).
The isolates were named according to their geographic origin (GER, UKR, KOS, CRO,
AFG), individual source (military dog—MD, stray dog–SD, stray fox–SF, companion dog–
CD, environmental–EN, and number indicating specific animal), year and month of isolation,
bacterial species and a running number within the present project; e.g. GER_M-
D06_1505_Eco_007 (S1 Table).
Whole genome analysis confirmed the species identification for the investigated isolates
except for two isolates: the Enterobacter kobei isolate GER_MD16_1505_Esp_090 was labeled
Enterobacter sp. and the Pseudomonas fulva isolate AFG_SD02_1510_Psp_092 was labeled
Pseudomonas sp. due to low measures of identity to reference genomes for each species.
In vitro antimicrobial susceptibility testing
All recovered isolates were tested in vitro for their antimicrobial resistance profile using the
commercially available standard micro-dilution system, MICRONAUT-S Beta-Lactamases
(Merlin, Berlin, Germany). This method included tests for six different singular antimicrobial
substances, including, cefoxitin (COX), cefotaxime (CTX), ceftazidime (CAZ), cefepime
(CEP), ertapenem (ERT), and meropenem (MER), and three additional combinations com-
prised of CTX, CAZ, and CEP tested in combination with clavulanic acid. The minimum
inhibitory concentration (MIC) was determined for each isolate in accordance with the manu-
facturer’s directions (Merlin, Berlin, Germany).
To assess the presence of multiple beta-lactamases (multiple resistance determinants) MIC
values were interpreted according to the breakpoint-value standards set for drug selection and
interpretation by the Clinical and Laboratory Standards Institute (CLSI, Wayne, PA, USA).
Specifically, the CLSI Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that
Grow Aerobically, 27th Informational Supplement (M100-S27), and the VET01/ VET01-S2
guidelines, Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for
Bacteria Isolated From Animals, presented by the Subcommittee on Veterinary Antimicrobial
Susceptibility Testing were used [21–22]. Complete breakpoint values were solely available for
E. coli and P. mirabilis and partially available for CEP and CAZ for Pseudomonas aeruginosa.
However, no breakpoints were available for Enterobacter spp., Aeromonas sp. and Pseudomo-
nas sp. other than P. aeruginosa [21]. By definition, extended-spectrum beta-lactamase is pro-
duced by a bacterium if more than a three twofold concentration decrease in a MIC is
observed for either antimicrobial agent tested in combination with clavulanic acid versus the
MIC of the agent when tested alone [22].
Genome sequencing, assembly, MLST
Whole genome sequencing was attempted for all isolates. DNA was extracted using the
QIAamp DNA Mini Kit (QIAGEN, Hilden, Germany), and sequenced on the Illumina MiSeq
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and NextSeq platforms (TGen, Flagstaff, AZ, USA). Raw sequence data were assembled with a
pipeline that includes Trimmomatic for read trimming [23], SPAdes v3.10.1 for contig assem-
bly [24], Pilon for assembly polishing [25], and BLAST to identify potential sequence contami-
nation [26]. In silico multi-locus sequencing typing (MLST) of identified E. coli genomes was
carried out using a custom script (https://gist.github.com/jasonsahl/2eedc0ea93f90097890
879e56b0c3fa3) that utilizes BLAST and the PubMLST database (https://pubmlst.org/) for
Escherichia coli [26–27].
Screening for CDS associated with antimicrobial resistance and virulence
factors
All recovered genome assemblies were screened for antibiotic resistance genes with ABRicate
(https://github.com/tseemann/abricate), using the ResFinder database (downloaded 2017 July
8) [28]. In addition, virulence gene profiles were determined by screening the genome assem-
blies for selected virulence coding DNA sequences (CDSs) with the large-scale blast score ratio
(LS-BSR) pipeline [29] using the BLAT alignment option [30]. Screened virulence genes
included 35 publicly available CDSs for fimbriae, toxins, and other proteins responsible for
adhesion, agglutination, gene transfer, or iron acquisition. A CDS was considered as present
within a genome if the blast score ratio was above 0.8 [31].
Phylogenetic analyses
Phylogenetic analyses were applied to all of the recovered E. coli sequences to identify genetic
relationships among the isolates. The E. coli genomes were compared to a reference, K-12
W3110 (GCA_000010245.1), and core genome single nucleotide polymorphisms (SNPs) were
identified [32]. Specifically, sequencing reads were aligned to the reference with BWA-MEM
[33]. SNPs were called using the UnifiedGenotyper method in GATK [34–35]. Putative SNP
positions with less than 10X coverage or allele proportions less than 90% were filtered from the
analysis. Any SNP identified from duplicated regions of the reference, as identified through
NUCmer [36] self-alignments, were filtered from downstream analyses. All of the SNP detec-
tion methods were performed in conjunction with the NASP pipeline [37]. Phylogenies were
inferred from the identified SNPs with IQ-TREE v 1.4.4 using the identified best-fit model,
TVM+ASC+G4 (S3 Table) [38].
Results
Isolates
In total, 101 bacterial isolates were recovered using the selective Brilliance ESBL AGAR
between January 2015 and June 2016 (S1 Table). Of these, 75 originated from 16 German mili-
tary dogs, with an additional five originating from two companion dogs (GER_CD71,
GER_CD72) living in the same household as German military dog GER_MD77. Of the foreign
isolates, six originated from stray dogs (n = 2), shelter dogs (n = 3), and a stray fox (n = 1) in
Kosovo; eight originated from stray dogs in Afghanistan; three originated from a Ukrainian
military dog located in Kosovo; and two originated from a Croatian military dog located in
Afghanistan (S1 Table). Two additional isolates originated from routine hygiene samples in
Germany, and were considered as outgroups of non-animal origin.
Isolates were recovered from 16 of the 20 tested German military dogs. However, repeat iso-
lation of ESBL-producing bacteria from samples taken on different dates was only successful
for five of the 17 German military dogs in the longitudinal study (29%) (S1 Table). The longi-
tudinal collection identified twelve isolates from GER_MD01 over a period of eleven months,
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five isolates from GER_MD02 over a period of seven months, ten isolates from GER_MD03
over a period of three months, four isolates from GER_MD06 over a period of seven months,
and eight isolates from GER_MD14 over a period of seven months (S1 Table).
A total of 31 isolates were collected from either the same dog or household within a single
month of sampling, allowing for an examination of ESBL-diversity within a single dog and/or
household over a short period of time. These included three isolates from GER_MD07, three
isolates from GER_MD08, 13 isolates from GER_MD11, two isolates from GER_MD17, seven
isolates from GER_MD77 or his companions GER_CD71 and GER_CD72, and three isolates
from UKR_MD01 (S1 Table).
Identification of the 101 isolates revealed 93 Escherichia coli, one Proteus mirabilis, two
Enterobacter cloacae, one Enterobacter sp. (all family Enterobacteriaceae), one Aeromonas
caviae, one Aeromonas hydrophila, one Pseudomonas aeruginosa, and one Pseudomonas sp.
(S1 Table). For two isolates, the identification was possible only on genus level due to contra-
dictory results based on the MALDI-TOF and the molecular approach.
Antimicrobial susceptibility
MICs for the entire antibiotic test panel were recovered for all isolates (S2 Table). Interpreta-
tion of MICs was carried out for the 94 isolates (E. coli, P. mirabilis) in accordance with CLSI
criteria. Due to limited or missing MIC values in the CLSI guidelines, interpretation was
restricted for CAZ and CEP for the P. aeruginosa isolate and could not be performed for the
Enterobacter, Aeromonas and Pseudomonas non-aeruginosa isolates (S2 Table). For COX, rep-
resenting cephamycin antibiotics within the 2nd generation of cephalosporins, 13 isolates
(14%) were resistant and 81 (86%) were susceptible (S2 Table). For CTX, representing 3rd gen-
eration cephalosporins, 91 isolates (97%) were resistant, one (1%) was susceptible, and two
(2%) had an intermediate state. For CAZ, 34 isolates (36%) were resistant, 51 (54%) were sus-
ceptible, and ten had an intermediate state (S2 Table). For CEP, a 4th generation cephalospo-
rin, 87 isolates (92%) were resistant, six (6%) were susceptible, and two (2%) had an
intermediate state (S2 Table). For the carbapenems, ERT and MER, all tested isolates were sus-
ceptible (S2 Table). Tests of CTX, CAZ, and CEP with the addition of 4 μg/ml clavulanic acid
to inhibit beta-lactamase activity, revealed 88 (93%) out of 95 isolates to be real ESBL-produc-
ers in the in vitro system and according to the CLSI guidelines (S2 Table) [21–22]. One isolate,
GER_MD01_1509_Eco_059, was susceptible to all of the tested substances (S2 Table).
Genome assembly and CDS identification
Draft genome assemblies were generated for 93 isolates, with the remaining eight isolates
excluded due to poor sequence quality (S3 Table). Of these, 85 were identified as E. coli
genomes. Genome assemblies were submitted to GenBank and raw data was submitted to the
sequence read archive (see S3 Table for individual accession numbers).
Use of ABRicate and the ResFinder database revealed sequence hits for 23 of 1,309 screened
CDSs for beta-lactamases amongst the genome assemblies (Table 1 and S4 Table). Regarding
class A beta-lactamase genes, 74 of 85 analyzed E. coli genomes possessed at least one CTX-M-
type beta-lactamase CDS, with 33 positive for blaCTX-M-1, 28 positive for blaCTX-M-15, eleven
positive for blaCTX-M-14, two positive for blaCTX-M-3, and one positive for blaCTX-M-2. One iso-
late was positive for blaSFO-1 and another for blaSHV-12. Forty isolates possessed blaTEM-1-type
beta-lactamase CDSs, with two positive for blaTEM-1A and 38 positive for blaTEM-1B (Table 1
and S4 Table). Regarding class B beta-lactamases, one A. hydrophilia genome was positive for
blaCph-A1 and three E. coli genomes were positive for blaVIM-1 (Table 1). Ten genomes were
positive for class C beta-lactamase CDSs, including three E. coli genomes positive for blaACC-1
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and single isolates positive for blaACT-7, blaACT-14, blaCMY-2, blaMIR-6, blaMOX-5, blaMOX-6, bla-
PAO, and ampH, respectively (Table 1 and S4 Table). Twenty isolates were positive for class D
beta-lactamase CDSs, including 18 E. coli genomes positive for blaOXA-1, one P. aeruginosa
positive for blaOXA-50, and one A. caviae positive for blaOXA-504 (Table 1 and S4 Table). Only
two isolates, the GER_MD10_1505_Pmi_049, and the GER_EN02_1501_Eco_088 were nega-
tive for all of the 1,309 screened beta-lactamase CDSs (Table 1 and S4 Table).
Patterns in the identified antimicrobial resistance CDSs suggested bacterial species spe-
cificity (Table 1). The two E. cloacae isolates were the only isolates to possess blaACT-7 and
blaACT-14, respectively. Likewise, the further Enterobacter sp. isolate was the only isolate to pos-
sess blaMIR-6, the P. aeruginosa isolate was the only isolate to possess blaPAO and blaOXA-50, and
the A. caviae isolate was the only isolate positive for blaMOX-6 and blaOXA-504. Similarly, the
A. hydrophila isolate was the only isolate positive for blaSFO-1, blaCph-A1, blaMOX-5, and ampH,
four antimicrobial resistance coding beta-lactamase genes and the highest number detected in
a single isolate (Table 1).
Sequence hits for seven of 35 screened virulence CDSs were detected among the genome
assemblies originating from the present study group (Table 2). Sequence hits included eleven
isolates positive for an adhesion protein CDS (i.e., the long polar fimbriae lpfA), one isolate
positive for the agglutination protein temperature sensitive hemagglutinin CDS (tsh). A CDS
Table 1. Prevalence of 23 specific beta-lactamase (BL) genes coding for antimicrobial resistance showing a clear species specificity (also S4 Table).
category BL, extended-spectrum BL (ESBL) specific resistance
gene
positive strains (n) out of
93
bacterial species
class A BL (penicillinase) cefotaximase-Munich, ESBL blaCTX-M-1 33 Escherichia coli
blaCTX-M-2 1 Escherichia coli
blaCTX-M-3 2 Escherichia coli
blaCTX-M-14 11 Escherichia coli
blaCTX-M-15 28 Escherichia coli
Serratia fonticola class A BL blaSFO-1 1 Aeromonas hydrophila
sulphydryl variable class A BL blaSHV-12 1 Escherichia coli
Temoneira, class A BL blaTEM-1A 2 Escherichia coli
blaTEM-1B 38 Escherichia coli
class B BL
(carbapenemase)
carbapenem-hydrolyzing metallo BL blaCph-A1 1 Aeromonas hydrophila
zinc dependent Verona integron-encoded metallo BL blaVIM-1 3 Escherichia coli
class C BL
(cephalosporinase)
Ambler class C-1 cephalosporin-hydrolyzing class C BL blaAcc-1 3 Escherichia coli
ampicillin type cephalosporin-hydrolyzing class C BL blaAct-7 1 Enterobacter cloacae
blaAct-14 1 Enterobacter cloacae
aminopenicillin-inactivating (Amp) cephalosporinase blaAmpH 1 Aeromonas hydrophila
cephamycinase, plasmid derived pYMG-1 bla blaCMY-2 1 Escherichia coli
methoxy-/ imino-Res; cephalosporin-hydrolyzing class C
BL
blaMIR-6 1 Enterobacter sp.
moxalactam-inactivating cephalosporinase blaMOX-5 1 Aeromonas hydrophila
blaMOX-6 1 Aeromonas caviae
Pseudomonas aeruginosa cephalosporinase blaPAO 1 Pseudomonas
aeruginosa
class D BL oxacillin-hydrolyzing BLs blaOXA-1 18 Escherichia coli
blaOXA-50 1 Pseudomonas
aeruginosa
blaOXA-504 1 Aeromonas caviae
https://doi.org/10.1371/journal.pone.0206252.t001
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catalyzing site specific integration into chromosome and responsible for horizontal gene trans-
fer (argW tRNA gene) was detected in 20 of the isolates [39–40]. The CDS for iron acquisition,
and iron carrier system, siderophore receptor A (ireA) was detected in four of the isolates [41].
Regarding toxin production, one isolate was positive for E. coli heat-stable (ST) enterotoxin A
(estA) and the ETEC heat-stable enterotoxin (STp). Finally, four isolates were positive for Shi-
gella enterotoxin B (senB) (Table 2). No isolate possessed more than two of the detected viru-
lence CDSs (S1 Table).
MLST, SNPs and phylogenetic analysis
The MLST, SNP and phylogenetic analyses were limited to the E. coli sequences. Of the 85
identified E. coligenomes, 81 could be classified as one of 31 out of> 7,000 known E. coli
sequence types (STs) based on MLST. The most frequently identified STs were ST744 (n = 9),
ST10 (n = 8), ST648 (n = 6), ST58 (n = 4), and ST315 (n = 4), with the remaining 26 STs repre-
sented�3 times among the 85 genomes (Fig 1 and S1 Table). The remaining four E. coli
genomes each contained one or two novel MLST alleles, resulting in three new, as yet unas-
signed STs (S1 Table). Phylogenetic analysis of 215,629 concatenated SNPs identified among
the core genome of the analyzed E. coli isolates revealed clustering consistent with the identi-
fied STs (Fig 1). Within MLST ST10, ST101, and ST58, the SNP analysis revealed higher dis-
criminatory power than pure MLST. Isolates belonging to these STs were collected on
different dates, from different dogs and possessed different resistance CDSs (Fig 1, S3 Table).
No clustering according to the geographic origin was observed among the study isolates, as
most isolates from KOS, AFG, UKR, and CRO revealed different MLST STs, CDSs contents,
and phylogenetic SNP clustering (Fig 1 and S1 Table).
In three cases, identical clones were detected from different dogs living in close contact.
First, the combination of blaCTX-M-14 and blaTEM-1B was found in nine ST744 clonal isolates
originating from five different dogs isolated within the same month (Fig 1 and S1 Table). Sec-
ond, the six ST648 isolates, originating from two different dogs in the same month, were the
only isolates found to contain the combination of blaCTX-M-15 and blaOXA-1 (Fig 1 and S1 Table).
Finally, three ST410 isolates, collected from three different dogs over five months, were all found
to contain blaCTX-M-15 and blaOXA-1. However, the isolate recovered five months after the other
two did differ somewhat in that it was found to lack the senB gene (Fig 1 and Table 2). In one
household, three dogs shed three ESBL-producing E. coli with identical MLST ST58 within 18
days, but these possessed SNP and gene content differences (GER_MD77_1507_Eco_075,
GER_CD72_1507_082) (Fig 1 and S1 and S3 Tables). Focusing only on clonal isolates within lon-
gitudinal reshedding in individual dogs, a maximum isolation-time difference of seven days could
Table 2. Virulence genes detected in the isolates of the present study using whole genome sequence analysis.
Protein
function
Gene Full name and effect Number of isolates carrying the
respective gene
Accession Number
adhesion lpfA long polar fimbriae 11 AB161111.1
agglutination tsh temperature sensitive hemagglutinin, autotransporter protein 1 AF218073.1
gene transfer argW tRNA gene; site specific integration into chromosome and horizontal
gene transfer
20 U11296.1
iron acquisition ireA Siderophore, iron carrier receptor 4 KU295572.1
toxin estA E. coli heat stable toxin A/ +variant 1 (environment) AF005091.1
toxin STp ETEC heat-stable enterotoxin 1 (environment) FN649417.1:c57269-
57051
toxin senB Shigella enterotoxin B 4 Z54195.1
https://doi.org/10.1371/journal.pone.0206252.t002
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GER MD77 1507 Eco 077 ST 162
GER MD03 1505 Eco 005 ST 315
GER MD03 1505 Eco 006 ST 101
GER MD14 1511 Eco 063 ST 90
AFG SD07 1510 Eco 097 ST N
GER MD02 1511 Eco 060 ST 23
GER MD11 1505 Eco 021 ST 48
GER MD01 1509 Eco 054 ST 1163
GER MD67 1606 Eco 100 ST 345
GER MD01 1505 Eco 048 ST 101
AFG SD04 1510 Eco 094 ST 181
GER MD01 1505 Eco 004 ST 10
GER CD71 1507 Eco 079 ST 1056
GER CD72 1507 Eco 082 ST 58
GER MD06 1511 Eco 065 ST 23
GER EN02 1501 Eco 088 ST 120
GER MD15 1507 Eco 052 ST 1662
GER MD03 1505 Eco 018 ST 744
GER MD03 1507 Eco 050 ST 973
GER MD01 1509 Eco 057 ST 868
GER MD01 1509 Eco 058 ST 398
GER MD06 1505 Eco 007 ST 744
GER MD02 1505 Eco 034 ST 744
UKR MD01 1506 Eco 067 ST 10
KOS DS01 1507 Eco 070 ST 10
GER MD11 1505 Eco 029 ST 2325
GER MD14 1507 Eco 051 ST 1662
GER MD14 1505 Eco 043 ST 648
GER MD06 1505 Eco 002 ST 744
GER MD90 1604 Eco 099 ST 372
GER MD08 1505 Eco 019 ST 88
GER CD71 1507 Eco 078 ST 1056
GER MD02 1511 Eco 064 ST 410
GER MD17 1505 Eco 039 ST 648
KOS SD04 1507 Eco 073 ST 155
GER MD14 1505 Eco 037 ST 648
GER MD01 1505 Eco 009 ST 10
GER MD03 1505 Eco 010 ST 744
GER MD14 1505 Eco 038 ST 648
GER MD07 1505 Eco 013 ST 681
GER MD03 1505 Eco 016 ST 315
UKR MD01 1506 Eco 069 ST 69
GER MD01 1509 Eco 055 ST 1163
GER MD07 1505 Eco 012 ST 681
GER MD11 1505 Eco 042 ST 2459
GER MD07 1505 Eco 014 ST 681
GER MD11 1505 Eco 025 ST 48
GER MD11 1505 Eco 030 ST 744
Reference Ecoli str K-12 substr W3110 ST 10
GER MD11 1505 Eco 024 ST N
GER MD11 1505 Eco 031 ST N
GER MD01 1505 Eco 047 ST 101
GER MD03 1505 Eco 011 ST 744
GER MD17 1505 Eco 045 ST 648
GER MD02 1505 Eco 040 ST 744
AFG SD08 1510 Eco 098 ST N
GER MD11 1505 Eco 026 ST 744
GER MD08 1505 Eco 035 ST 88
GER MD01 1509 Eco 059 ST 868
GER MD03 1505 Eco 041 ST 973
GER MD06 1511 Eco 062 ST 410
AFG SD06 1510 Eco 096 ST 3586
GER CD72 1507 Eco 080 ST 58
GER MD77 1507 Eco 075 ST 58
GER MD14 1507 Eco 053 ST 1662
CRO MD01 1509 Eco 084 ST 2450
GER MD01 1603 Eco 066 ST 453
AFG SD05 1510 Eco 095 ST 3586
GER EN01 1501 Eco 087 ST 10
GER MD11 1505 Eco 023 ST 2325
GER MD11 1505 Eco 036 ST 2459
GER MD11 1505 Eco 020 ST 2459
GER MD01 1505 Eco 001 ST 10
KOS SD05 1507 Eco 074 ST 127
KOS SF06 1605 Eco 101 ST 10
GER MD11 1505 Eco 027 ST 2325
GER MD03 1505 Eco 017 ST 58
GER MD14 1505 Eco 044 ST 648
GER MD03 1505 Eco 003 ST 315
KOS DS02 1507 Eco 071 ST 162
UKR MD01 1506 Eco 068 ST 10
GER MD02 1511 Eco 061 ST 23
GER MD03 1505 Eco 015 ST 315
GER MD01 1509 Eco 056 ST 868
GER MD11 1505 Eco 032 ST 48
GER CD72 1507 Eco 081 ST 410
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be shown for five dogs (GER_MD03, GER_MD07, GER_MD08, GER_MD11, GER_MD14) (Fig
1 and S1 Table).
Discussion
We collected 101 bacterial isolates during a 12-month ESBL-screening study of clinically
healthy dogs and characterized their antimicrobial resistance phenotypes and genotypes
through in vitro testing and whole genome sequence analysis. Here, 16 of 20 German military
dogs (80%) that had no history of medical treatment for the previous twelve months were
found to shed ESBL-producing bacteria at least once within the study period (S1 Table).
Although a high prevalence of ESBL-producing bacteria is suspected in livestock, our findings
were surprising considering that the investigated animals were clinically healthy and untreated
[42]. Also concerning was the result that 9% of the characterized E. coli isolates from clinically
healthy German dogs were completely resistant against all tested cephalosporins (COX, CTX,
CAZ, and CEP) (S2 Table). As the microbiological resistance against third-generation cephalo-
sporins in European countries was stated as generally low in a review of 2012 data provided by
the European Centers for Disease Control (ECDC), this result can be interpreted as a trend
towards increasing multidrug resistance [43].
The overall trends of increasing antimicrobial resistance have led to several actions in
recent years. In 2015, increasing concern on the animal welfare consequences of antimicrobial
resistance in bacteria from animal sources led to the establishment of a sub-committee for Vet-
erinary Antimicrobial Susceptibility Testing (VetCAST) of the European Committee on Anti-
microbial Susceptibility Testing (EUCAST) [44]. In 2018, the national German veterinary
pharmacy regulation law was enforced. According to this law, if a veterinarian applies antibiot-
ics to animals, the MIC of bacterial isolates must be determined in case of repeated or change
of medication, rededication, or regarding therapy of flocks or regarding animals bred for spe-
cific purposes [45]. This enforcement was aimed at a reduction of the use of antibiotics, but as
well as at avoiding an increase of antimicrobial resistance through non-suitable therapy. Since
2014, the amounts and application of antibiotics in animal husbandry in Germany are offi-
cially collected in a large database. The Federal Veterinary Surgeons’ Association regularly
publish guidelines for the prudent use of veterinary antimicrobial drugs, and may consider
data regarding the use, but also antimicrobial resistance [46]. The data of the present study
contribute to comprehend trends within the complex field of antimicrobial resistance.
Resistance against single antibiotics within the class of cephalosporins was common among
the investigated isolates, with 14% of the evaluated isolates resistant to COX and 92% resistant
to CEP (S2 Table). COX is a 2nd generation cephamycin, frequently used in the treatment of
dogs and other companion animals [46]. CEP is a 4th generation cephalosporin limited to use
in humans, making the 92% resistance rate observed here unexpectedly high (S2 Table) [47].
These results should be considered when revising the drug application recommendations for
human and animal patients [21].
Among the currently available beta-lactams, the carbapenems, such as ERT and MER, are
antibiotics of last resort. They are unique in that they are resistant to a high degree against
hydrolysis by most beta-lactamases. They can sometimes act as “slow substrates” or inhibitors
of beta-lactamases, and, yet, still target penicillin-binding proteins [2]. Although carbapenems
Fig 1. Phylogenetic tree of 85 ESBL-producing E. coli. Phylogenetic analysis based on 215,629 concatenated SNPs
revealed clustering according to their MLST sequence type. E. coli K-12 substr W3110 was used as reference strain. All
genome sequences except for the reference strain, and the environmental isolate GER_EN02_1501 revealed genes
coding for antimicrobial resistance.
https://doi.org/10.1371/journal.pone.0206252.g001
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are limited to use in humans only, off-label use or prescription may allow animals to be treated
with these antibiotics [48]. In this study, we did not find any carbapenem resistance using the
in vitro microbouillon dilution method (S2 Table). The in silico analysis detected similarly low
levels of resistance, identifying only four isolates with a single carbapenemase CDS each (S4
Table). This suggests that dogs do not represent a likely source for the high rates of carbape-
nem resistance that have been published for hospital-acquired strains [49].
Antimicrobial resistance–in vitro and in silico analyses
Initial isolate selection was based on growth on supposedly ESBL- selective Brilliance ESBL
AGAR (Oxoid, Wesel, Germany) containing an unknown antibiotic-mix. The in vitro analysis
and subsequent interpretation according to current CLSI guidelines revealed 88 out of 95 iso-
lates to be actual ESBL-producers [21–22]. As there were no interpretation guidelines available
for six of the investigated bacterial isolates, including the Enterobacter spp., the Aeromonas
spp., and Pseudomonas species other than P. aeruginosa isolates, we did not assign these as
ESBL-producers in S2 Table [21–22]. However, for one out of these isolates (Aeromonas hydro-
phila), ESBL-activity according to the rule “more than a three twofold concentration decrease
comparing growth in the presence of CTX and CTX in combination with clavulanic acid” was
observed (S2 Table) [21]. Pure antimicrobial resistance without ESBL-activity revealed five out
of the investigated isolates. One more isolate, GER_EN01_1501_Eco_087, revealed an inter-
mediate status, and another isolate, GER_MD01_1509_Eco_059, did not even reveal antimi-
crobial resistance in the in vitro testing. Finally, the Pseudomonas aeruginosa isolate,
GER_MD14_1510_Pae_083, did not reveal ESBL-activity, it was considered as a susceptible
isolate according to the CLSI guidelines for CAZ and CEP (S2 Table) [21]. These results indi-
cate some lack of specificity for the selective Brilliance ESBL AGAR (Oxoid, Wesel, Germany).
We compared the in vitro results with the detection of ESBL-specific CDSs in the in silico anal-
ysis (S5 Table). The susceptible isolate GER_MD01_1509_Eco_059, and the intermediate iso-
late GER_EN01_1501_Eco_087 revealed a single ESBL-CDS each, blaTEM-1B and blaOXA-1,
respectively (S4 Table). In contrast, the two in vitro antimicrobial resistant isolates GER_E-
N02_1501_Eco_088 and GER_MD10_1505_Pmi_049 did not reveal any ESBL-CDSs at all (S5
Table). Although the results from the two methodologies do not match entirely, we consider
this a fairly high level of concordance between the in vitro and in silico analyses. It further sug-
gests that the initial screening method for ESBL-producers was not highly specific, as eight iso-
lates could grow on the selective media, but did not reveal true ESBL-properties (S2 Table).
The isolates GER_MD03_1507_Eco_050 and GER_MD11_1505_Eco_023 were found to
possess only a single beta-lactamase gene (S4 Table). However, they revealed multiple resis-
tance in vitro, against CTX and CEP, and were identified as ESBL-producers (S2 Table). In
vitro and in silico correlation is therefore still too complex to predict a particular resistance
from the result of a single detected beta-lactamase gene. Nevertheless, amongst the E. coli
ESBL-producers, the most frequent ESBL-specific CDSs were blaCTX-M1, blaCTX-M15, blaTEM-
1B, and blaOXA-1 in the present study, as it has been published (Table 1) [3, 11].
The investigated isolates belonged to six different bacterial species. Noticeably, the in silico
results showed strict bacterial species-specific CDS patterns regarding antimicrobial resistance
(Table 1). Although species specificity has been described for some of these resistance genes
such as the “Pseudomonas aeruginosa cephalosporinase” (blaPAO) [50], other classes can be
found within various bacterial species belonging to the family Enterobacteriaceae such as the
“sulphydryl variable class A beta-lactamase” (blaSHV) [1]. Finally, some beta-lactamases, such
as the “oxacillin-hydrolyzing beta-lactamase” (blaOXA), and the “cefotaximase-Munich
extended-spectrum beta-lactamase” (blaCTX-M), were described for genetically distant bacterial
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genera such as the Gram-positive Enterococcus and Gram-negative Escherichia [51]. Apart
from their presence, enzymes may also vary regarding their kinetic activity. The “Temoneira
class A beta-lactamases” (TEM-1) are able to hydrolyze ampicillin at a greater rate than carbe-
nicillin, oxacillin, or cephalothin, and have negligible activity against extended-spectrum ceph-
alosporins. Similar findings have been published for the CTX-M and OXA beta-lactamase
subtypes [1]. The isolate GER_MD90_1604_Eco_099 was revealed to be resistant against 2nd
and 3rd generation cephalosporins, COX, CTX, and CAZ (S2 Table). As previously published,
a single resistance CDS, the cephamycinase blaCMY-2, was likely responsible for this phenotype.
Interestingly, this isolate was not an ESBL-producer by definition (S4 Table) [14]. Therefore,
neither of the methods, either the phenotypic characterization nor whole genome analysis, can
completely replace the other due to lack of crucial information. Thus, it is currently not possi-
ble to predict the phenotype using pure whole genome analysis and vice versa. However, due
to its relevance for clinical diagnostics and treatment recommendations, the in vitro analysis
will likely remain the gold standard at this time [21]. Drawbacks to this method include the
fact that inoculum effects and in vitro conditions may affect MIC measurements, which may
obscure a true underlying resistance genotype in various bacterial species [51–54]. In addition,
non-Enterobacteriaceae organisms are currently not considered in CLSI guidelines for ESBL
detection, impeding treatment recommendations for clinical patients affected by other species
[1, 21].
In previous studies, PCR detection was used to identify individual CDSs of beta-lactamase
subgroups of blaCTX-M, blaCMY, blaTEM, blaSHV, blaPSE, blaOXA, blaAmpC, blaACC in isolates
originating from companion animals [3, 4, 10–12, 51, 55–60]. By utilizing whole genome
sequencing, we were able to identify seven additional beta-lactamase types and subtypes,
including, blaSFO, blaCph, blaVIM, blaAct, blaMIR, blaMOX, and blaPAO (Table 1 and S4 Table).
Similar findings have been published after the analysis of human derived ESBL-producing bac-
teria, reflecting the superior detection capabilities offered by whole genome sequence analysis
[17]. In summary, not using whole genome sequence analysis, an investigator risks missing
crucial information concerning antibiotic resistance that could be helpful and sometimes even
crucial for subsequent epidemiological interpretation.
Prevalence of specific MLST STs and resistance genes
By the year 2000, a CTX-M beta-lactamase producing ST131 E. coli was recognized as a clone
with worldwide prevalence, with about half of all hospital acquired ESBL-infections associated
with this sequence type [17, 61–63]. In the present study, ST131 was not detected among the
dog-derived isolates, suggesting that this ST might be less adapted to the canine host [64]. The
two most common MLST ST identified in the present study were ST744 and ST10, with nine
and eight isolates among the 85 isolates, respectively (Fig 1 and S1 Table). Several predominant
ESBL-producing E. coli lineages have been identified for animals. The MLST ST10 was repeat-
edly isolated from pigs in Ireland, ST410 from small animals in Switzerland, and finally ST38
and ST131 from poultry and small animals in the Netherlands [51, 65–67]. As the MLST ST10
dog-isolates of the present study originated from Germany, Kosovo, Ukraine and Afghanistan,
a significant geographic cumulation of MLST ST10 cannot be concluded from the present data
(Fig 1 and S1 Table).
Regarding the transmission and prevalence of certain beta-lactamase subtypes, it has been
suggested that human isolates hosting the CTX-M beta-lactamase subtypes vary by geographic
origin [17]. In Germany, the plasmid coded blaCTX-M-15 gene is the most frequent subtype
originating from human patient isolates [7, 62]. In the present study, blaCTX-M-15 was detected
in 30% (28 isolates with the gene out of 89 true ESBL-producers) of the isolates originating
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from Germany, however also from the countries Kosovo, Ukraine, Croatia, and Afghanistan
(S4 Table). As an additional 54% of isolates were found to carry blaCTX-M-subtypes other than
blaCTX-M-15 (S4 Table), it may be assumed that the CTX-M beta-lactamases have a generally
high prevalence, regardless of source.
A recent publication indicated large-scale transmission of hospital-associated blaIMP-carry-
ing isolates into wildlife after feeding of birds at a local waste depot [6]. But this finding could
not be supported by results of a study from the same year with hardly any confirmed transmis-
sion from 22 ESBL-positive humans to their companion dogs [68]. Hypotheses regarding
transmission pathways and reservoirs are often oversimplified in single studies whereas the
reality is far more complex [42].
Phylogeny
The bacterial species E. coli possesses great genetic diversity, with>7,000 identified MLST STs
[27]. Although the vast majority of E. coli is a prolific commensal part of the gut microbiome,
selected serotypes cause serious disease, including the enterohemorrhagic or extraintestinal
pathogenic E. coli (EHEC, ExPEC), which express various virulence and toxin genes [64, 69–
70]. Outbreak investigation revealed that an epidemiological linkage was estimated if two iso-
lates revealed the same MLST ST, and differed by less than ten core SNPs [17, 71]. In contrast,
antimicrobial resistance in E. coli is not restricted to specific clones, as it has been identified in
a broad variety of genotypes isolated from human and animal sources [11, 42, 51, 67, 70, 72].
We observed representative diversity among the 85 ESBL-producing E. coli characterized here,
with 34 different MLST STs, including three currently unassigned STs (Fig 1 and S1 Table).
Amongst the isolates belonging to MLST ST10, additional SNP diversity could be identified,
likely related to the different countries of origin for these isolates (Fig 1 and S3 Table).
In the present study, four clusters (ST744, ST648, ST410, ST23) were identified that
included isolates of different dog-origin that also showed similar beta-lactamase CDS profiles
and lacked SNP differences (Fig 1). This suggests that these isolates epidemiologically share
the same ancestor, which may be explained by mutual/ reciprocal transmission, as the dogs in
question regularly share the same training facility and runout (Fig 1). Similar findings were
recently published where low genetic diversity was described for 297 ST131 E. coli strains iso-
lated in a longitudinal study from a group of patients living in a long-term care facility, indicat-
ing acquisition from a common source or person-to-person transmission [63].
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